πŸ‡ΊπŸ‡Έ FDA
Patent

US 9725494

Soluble CD27 (sCD27) and the use thereof

granted A61KA61K2039/55516A61K38/1793

Quick answer

US patent 9725494 (Soluble CD27 (sCD27) and the use thereof) held by UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55516, A61K38/1793, A61K39/39